Headquartered in Indianapolis, Indiana, Beckman Coulter Life Sciences is a trusted global resource for tools and technologies to help optimize biopharmaceutical research and accelerate answers in laboratories around the world.

 

Centrifuges. Particle counters/analyzers. Automated and acoustic liquid handlers. Flow cytometers. Genomic reagents. All these products, and many more, continue to make a difference in people's lives-by improving the productivity of scientists dedicated to discovering new and better disease therapies.

 

An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter Life Sciences has more than 3,400 global associates, each committed to empowering those seeking answers to life's important scientific and healthcare questions. For details, visit beckman.com.

For 60 years The Baker Company has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment. Recognized as the industry pioneer, The Baker Company maintains an unparalleled passion for helping our customers advance science, discovery, and clinical care. The people of Baker have built that reputation by taking no chances with customers' safety and making no compromises when it comes to protecting the success of your research. Baker's laboratory products are built to order with precision craftsmanship and designed expressly for your unique application need. Our rigorous testing protocols go above and beyond what the average user would ever encounter and our quality control measures exceed industry standards. Our commitment to sustainable business practices and the development of a new generation of energy efficient products ensures that you - and your budget - will be pleased.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.

A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory's role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time - and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what's now to what's next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Beckman Coulter is part of the Danaher Corporation family of global science and technology companies. Headquartered in Brea, Calif., it has more than 11,000 global team members.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books (under the Bentham Books brand) have an ever-increasing readership of millions of researchers worldwide.

Binding Site is committed to improving patient lives worldwide through education, collaboration, and innovation. We do this by providing automated special protein instruments and a wide range of high quality assays, with over 20 new assays FDA cleared in 2013 and 2014. Binding Sites SPAPLUS special protein analyzer is the newest, most efficient, cost-effective, and reliable instrument solution available for special protein testing. With a comprehensive menu of over 30 assays, the SPAPLUS is the perfect complement for todays lab. The Freelite assays, developed and provided exclusively by Binding Site, are considered standard-of-care for the diagnosis of Myeloma and other monoclonal gammopathies. Binding Sites Hevylite assays are now available in the U.S. Hevylite is a novel test for measurement of Myeloma serum proteins. Hevylite test results are used together with Freelite in the management of Myeloma patients. Binding Site is also the market leader for IgG and IgA immunoglobulin subclass reagents. In addition to our in vitro diagnostic portfolio, we provide a comprehensive product offering of antibodies, antigens, clinical specimens, collaborative immunoassay reagents, disease state sera, substrates, and contact manufacturing services for IVD manufacturers and suppliers. The Freelite assays, developed and provided exclusively by Binding Site, are considered standard-of-care for the diagnosis of Myeloma and other monoclonal gammopathies and suppliers.

Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, helping people live longer, healthier lives.

Bio-Techne empowers researchers in Life Sciences and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services. Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results. Whether you are at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our innovative products and services provide the solutions you need to achieve success.

Biocompare (www.biocompare.com) is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information. Produced by scientists, Biocompare's mission is to provide free, time saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery. Biocompare does this by providing specialized search tools, articles, product reviews, webinars, videos and technology spotlights all designed to ensure that Biocompare remains a trusted and comprehensive source of product information. Biocompare continually strives to serve the life science community by providing new and improved online services that facilitate product discovery and technology education.

BioLegend develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, California. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., who was also the co-founder of PharMingen.

BioMed Central is an STM (Science, Technology and Medicine) publisher of 265 peer-reviewed open access journals. The portfolio of journals spans all areas of biology, biomedicine and medicine and includes broad interest titles, such as BMC Biology and BMC Medicine alongside specialist journals, such as Retrovirology and BMC Genomics. All original research articles published by BioMed Central are made freely accessible online immediately upon publication. BioMed Central levies an article-processing charge to cover the cost of the publication process. Authors publishing with BioMed Central retain the copyright to their work, licensing it under the Creative Commons Attribution License which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited. BioMed Central is owned by Springer Science+Business Media, and also hosts the SpringerOpen platform.

LGC Biosearch Technologies is a ISO 9001:2008 certified company, located in northern California. Founded in 1993, Biosearch is a leader in the design, development and manufacture of sophisticated oligonucleotide-based tools. Products include fluorophores (CAL Fluor®, Quasar® and Pulsar® dyes) and dark quenchers (Black Hole Quencher® dyes) to be included in custom-synthesized probe formats for real-time, quantitative PCR, Stellaris® RNA FISH, and other genomic-based applications.

BioTek Instruments, Inc., a part of Agilent Technologies, is a global leader in the development, manufacture and sale of life science instrumentation, including imaging & microscopy, multi-mode detection, liquid handling and automation systems. Our philosophy transcends conventional thinking and challenges the status quo. We develop fresh, original solutions by unifying concepts that often appear to be opposed. It means to shape and reshape. To engineer, build, deliver and support products that best serve the marketplace by providing what you need, when you need it.

Boster is an antibody manufacturer founded in 1993 by famed histologist, Steven Xia. Over the past two decades, Boster's products have been cited in over 12,000 publications. We specialize in developing ELISA kits and antibodies with high affinity and at affordable prices. One thing that sets us apart from our competitors is that we thoroughly test all antibodies using un-"spiked" (not transfected) tissues and cell lines to ensure they have enough affinity to react with the endogenous levels of the targets before providing them to our customers.

The global leader in automated sample management for drug discovery and biostorage applications. Part of Brooks Automation (Nasdaq:BRKS) the Company provides unparalleled experience in automated compound, biological storage and sample processing solutions.

Bruker offers advanced preclinical imaging and fluorescence microscopy solutions for a broad spectrum of application fields: oncology, neurology, cardiology, inflammation, infectious diseases, cancer research, functional and anatomical neuroimaging, orthopedics, cardiac imaging, stroke models, and in vivo imaging of the nervous system, optogenetics, in vitro imaging of brain slices in conjunction with electrophysiology, cellular imaging and imaging cell structure at the molecular level. Our range of techniques includes two-photon, confocal, and super-resolution fluorescence microscopes, magnetic resonance imaging (MRI), PET/MRI imaging, Optical Imaging, PET/SPECT/CT imaging, micro-CT and magnetic particle imaging (MPI) as well as MALDI Imaging.